437 related articles for article (PubMed ID: 25960998)
1. SNCA Gene, but Not MAPT, Influences Onset Age of Parkinson's Disease in Chinese and Australians.
Huang Y; Wang G; Rowe D; Wang Y; Kwok JB; Xiao Q; Mastaglia F; Liu J; Chen SD; Halliday G
Biomed Res Int; 2015; 2015():135674. PubMed ID: 25960998
[TBL] [Abstract][Full Text] [Related]
2. Variants in the SNCA gene associate with motor progression while variants in the MAPT gene associate with the severity of Parkinson's disease.
Wang G; Huang Y; Chen W; Chen S; Wang Y; Xiao Q; Liu J; Fung VS; Halliday G; Chen S
Parkinsonism Relat Disord; 2016 Mar; 24():89-94. PubMed ID: 26776090
[TBL] [Abstract][Full Text] [Related]
3. Independent and joint effects of the MAPT and SNCA genes in Parkinson disease.
Elbaz A; Ross OA; Ioannidis JP; Soto-Ortolaza AI; Moisan F; Aasly J; Annesi G; Bozi M; Brighina L; Chartier-Harlin MC; Destée A; Ferrarese C; Ferraris A; Gibson JM; Gispert S; Hadjigeorgiou GM; Jasinska-Myga B; Klein C; Krüger R; Lambert JC; Lohmann K; van de Loo S; Loriot MA; Lynch T; Mellick GD; Mutez E; Nilsson C; Opala G; Puschmann A; Quattrone A; Sharma M; Silburn PA; Stefanis L; Uitti RJ; Valente EM; Vilariño-Güell C; Wirdefeldt K; Wszolek ZK; Xiromerisiou G; Maraganore DM; Farrer MJ;
Ann Neurol; 2011 May; 69(5):778-92. PubMed ID: 21391235
[TBL] [Abstract][Full Text] [Related]
4. SNCA and MAPT genes: Independent and joint effects in Parkinson disease in the Italian population.
Trotta L; Guella I; Soldà G; Sironi F; Tesei S; Canesi M; Pezzoli G; Goldwurm S; Duga S; Asselta R
Parkinsonism Relat Disord; 2012 Mar; 18(3):257-62. PubMed ID: 22104010
[TBL] [Abstract][Full Text] [Related]
5. Do interactions between SNCA, MAPT, and LRRK2 genes contribute to Parkinson's disease susceptibility?
Biernacka JM; Armasu SM; Cunningham JM; Ahlskog JE; Chung SJ; Maraganore DM
Parkinsonism Relat Disord; 2011 Dec; 17(10):730-6. PubMed ID: 21816655
[TBL] [Abstract][Full Text] [Related]
6. Genetic Variants of SNCA Are Associated with Susceptibility to Parkinson's Disease but Not Amyotrophic Lateral Sclerosis or Multiple System Atrophy in a Chinese Population.
Chen Y; Wei QQ; Ou R; Cao B; Chen X; Zhao B; Guo X; Yang Y; Chen K; Wu Y; Song W; Shang HF
PLoS One; 2015; 10(7):e0133776. PubMed ID: 26208350
[TBL] [Abstract][Full Text] [Related]
7. SNCA, MAPT, and GSK3B in Parkinson disease: a gene-gene interaction study.
Wider C; Vilariño-Güell C; Heckman MG; Jasinska-Myga B; Ortolaza-Soto AI; Diehl NN; Crook JE; Cobb SA; Bacon JA; Aasly JO; Gibson JM; Lynch T; Uitti RJ; Wszolek ZK; Farrer MJ; Ross OA
Eur J Neurol; 2011 Jun; 18(6):876-81. PubMed ID: 21159074
[TBL] [Abstract][Full Text] [Related]
8. Assessment of risk factor variants of LRRK2, MAPT, SNCA and TCEANC2 genes in Hungarian sporadic Parkinson's disease patients.
Boros FA; Török R; Vágvölgyi-Sümegi E; Pesei ZG; Klivényi P; Vécsei L
Neurosci Lett; 2019 Jul; 706():140-145. PubMed ID: 31085292
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants.
Heckman MG; Elbaz A; Soto-Ortolaza AI; Serie DJ; Aasly JO; Annesi G; Auburger G; Bacon JA; Boczarska-Jedynak M; Bozi M; Brighina L; Chartier-Harlin MC; Dardiotis E; Destée A; Ferrarese C; Ferraris A; Fiske B; Gispert S; Hadjigeorgiou GM; Hattori N; Ioannidis JP; Jasinska-Myga B; Jeon BS; Kim YJ; Klein C; Kruger R; Kyratzi E; Lin CH; Lohmann K; Loriot MA; Lynch T; Mellick GD; Mutez E; Opala G; Park SS; Petrucci S; Quattrone A; Sharma M; Silburn PA; Sohn YH; Stefanis L; Tadic V; Tomiyama H; Uitti RJ; Valente EM; Vassilatis DK; Vilariño-Güell C; White LR; Wirdefeldt K; Wszolek ZK; Wu RM; Xiromerisiou G; Maraganore DM; Farrer MJ; Ross OA;
Neurobiol Aging; 2014 Jan; 35(1):266.e5-14. PubMed ID: 23962496
[TBL] [Abstract][Full Text] [Related]
10. alpha-Synuclein and Parkinson disease susceptibility.
Winkler S; Hagenah J; Lincoln S; Heckman M; Haugarvoll K; Lohmann-Hedrich K; Kostic V; Farrer M; Klein C
Neurology; 2007 Oct; 69(18):1745-50. PubMed ID: 17872362
[TBL] [Abstract][Full Text] [Related]
11. Common variants in PARK loci and related genes and Parkinson's disease.
Chung SJ; Armasu SM; Biernacka JM; Lesnick TG; Rider DN; Lincoln SJ; Ortolaza AI; Farrer MJ; Cunningham JM; Rocca WA; Maraganore DM
Mov Disord; 2011 Feb; 26(2):280-8. PubMed ID: 21412835
[TBL] [Abstract][Full Text] [Related]
12. Different MAPT haplotypes influence expression of total MAPT in postmortem brain tissue.
Tauber CV; Schwarz SC; Rösler TW; Arzberger T; Gentleman S; Windl O; Krumbiegel M; Reis A; Ruf VC; Herms J; Höglinger GU
Acta Neuropathol Commun; 2023 Mar; 11(1):40. PubMed ID: 36906636
[TBL] [Abstract][Full Text] [Related]
13. Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression.
Davis AA; Andruska KM; Benitez BA; Racette BA; Perlmutter JS; Cruchaga C
Neurobiol Aging; 2016 Jan; 37():209.e1-209.e7. PubMed ID: 26601739
[TBL] [Abstract][Full Text] [Related]
14. Tau haplotypes regulate transcription and are associated with Parkinson's disease.
Kwok JB; Teber ET; Loy C; Hallupp M; Nicholson G; Mellick GD; Buchanan DD; Silburn PA; Schofield PR
Ann Neurol; 2004 Mar; 55(3):329-34. PubMed ID: 14991810
[TBL] [Abstract][Full Text] [Related]
15. Replication of MAPT and SNCA, but not PARK16-18, as susceptibility genes for Parkinson's disease.
Mata IF; Yearout D; Alvarez V; Coto E; de Mena L; Ribacoba R; Lorenzo-Betancor O; Samaranch L; Pastor P; Cervantes S; Infante J; Garcia-Gorostiaga I; Sierra M; Combarros O; Snapinn KW; Edwards KL; Zabetian CP
Mov Disord; 2011 Apr; 26(5):819-23. PubMed ID: 21425343
[TBL] [Abstract][Full Text] [Related]
16. SNCA: major genetic modifier of age at onset of Parkinson's disease.
Brockmann K; Schulte C; Hauser AK; Lichtner P; Huber H; Maetzler W; Berg D; Gasser T
Mov Disord; 2013 Aug; 28(9):1217-21. PubMed ID: 23674386
[TBL] [Abstract][Full Text] [Related]
17. Alpha-synuclein gene polymorphism affects risk of dementia in Han Chinese with Parkinson's disease.
Zheng J; Zang Q; Hu F; Wei H; Ma J; Xu Y
Neurosci Lett; 2019 Jul; 706():146-150. PubMed ID: 31102707
[TBL] [Abstract][Full Text] [Related]
18. Association analysis of the GRN rs5848 and MAPT rs242557 polymorphisms in Parkinson's disease and multiple system atrophy: a large-scale population-based study and meta-analysis.
Chen Y; Cao B; Ou R; Chen X; Zhao B; Wei Q; Wu Y; Shang HF
Int J Neurosci; 2016 Oct; 126(10):947-54. PubMed ID: 26303052
[TBL] [Abstract][Full Text] [Related]
19. Genetic variants of SNCA and LRRK2 genes are associated with sporadic PD susceptibility: a replication study in a Taiwanese cohort.
Wu-Chou YH; Chen YT; Yeh TH; Chang HC; Weng YH; Lai SC; Huang CL; Chen RS; Huang YZ; Chen CC; Hung J; Chuang WL; Lin WY; Chen CH; Lu CS
Parkinsonism Relat Disord; 2013 Feb; 19(2):251-5. PubMed ID: 23182315
[TBL] [Abstract][Full Text] [Related]
20. Microtubule-associated protein tau (MAPT) influences the risk of Parkinson's disease among Indians.
Das G; Misra AK; Das SK; Ray K; Ray J
Neurosci Lett; 2009 Aug; 460(1):16-20. PubMed ID: 19450659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
